A clinical trial testing a new Oxford / AstraZeneca vaccine against Covid-19 has opened to recruitment at Barts Health NHS Trust. Volunteers are needed to take part in the study (a phase II/III clinical trial), which is led by the University of Oxford and AstraZeneca and supported by the National Institute of Health Research. The trial aims to test the...
Professor Sir Mark Caulfield has been announced as the new Chief Executive Officer of Barts Life Sciences. Barts Life Sciences, a research and innovation partnership between Barts Health NHS Trust and Queen Mary University of London, is driving the development of a world-leading life sciences campus at Whitechapel focusing on digital health, genomics and clinical innovation. The programme aims to develop...
***PRESS RELEASE*** We are delighted to welcome the 49 interns participating in our 2021 Black Internship Programme. As the UK’s national institute for health data science and the alliance of UK health data custodians, Health Data Research UK (HDR UK) and UK Health Data Research Alliance (the Alliance) hope to help transform the prospects of and provide the opportunities for, young Black people in the UK, allowing them to flourish in their future science,...
COVID-19 has accelerated data-driven innovation across the globe, with AI and data science at the forefront of addressing human disease and health. Read London & Partners and MedCity’s new report on London’s strengths as a hub for health & life sciences: https://adobe.ly/3cvSfOC
Barts Health is one of the largest NHS trusts in the country, and one of Britain’s leading healthcare providers. The Barts Health group of NHS hospitals is entering an exciting new era on our improvement journey to becoming an outstanding organisation with a world-class clinical reputation. Having lifted ourselves out of special measures, we now have the impetus and breathing...
Led by UKRI Rutherford research fellow Dayem Ullah and Professor of bioinformatics Claude Chelala, Barts Cancer Institute and Queen Mary University of London have published a study on the effects of COVID-19 in patients with hepatobiliary and pancreatic diseases in East London Read the full article here: https://bmjopen.bmj.com/content/11/4/e045077.full
Scientists from Queen Mary University of London, funded by the charity Brain Tumour Research and the Medical Research Council, have found a new way to starve cancerous brain tumour cells of energy in order to prevent further growth. The pre-clinical research in human tissue samples, human cell lines and mice could lead to changes in the way that some children...
An observational study by Queen Mary University of London researchers in nearly 20,000 individuals has found that greater intake of red and processed meat is associated with worse heart function. The research is presented at ESC Preventive Cardiology 2021, an online scientific congress of the European Society of Cardiology (ESC) and published in the journal Frontiers in Cardiovascular Medicine. Study author...
Queen Mary University of London researchers have been awarded a £300,000 grant to study the impact of air pollution on children’s brain function and mental health. The team will examine the impact of London’s Ultra Low Emission Zone on children’s brain development after receiving the funding from Barts Charity. The CHILL COGNITION study will run over a three year period...
A new smell test developed by Queen Mary University of London researchers has been found to be easy to use in patients with Parkinson’s disease, and could also be helpful in diagnosing COVID-19 in the broader population. Smell tests have the potential to support the diagnosis of certain neurological conditions, including Parkinson’s and Alzheimer’s. Unfortunately, these tests are not widely...
Accessibility options
Translate the page